Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

Corporate Money Wins: GMO Labeling Bill Betrays Consumers

Popular

On March 12, 1930, Mahatma Gandhi and a small band of supporters set off on a 241-mile march across western India. Gandhi had devised the walk as an act of nonviolent protest against the British colonial government's salt monopoly, which placed tariffs on the mineral and forbid Indians from producing it. Upon arriving at the coastal city of Dandi in early April, he illegally collected salt from the seaside as a symbolic act of defiance against the British Raj. His actions sent shockwaves across the subcontinent, inspiring scores of Indians to flout the salt tax and launch strikes and boycotts against colonial institutions. Gandhi and some 80,000 others were soon arrested, but not before their peaceful protest had captured the world's attention and demonstrated the power of mass resistance to British rule. — Remembering Gandhi's Salt March, by Evan Andrews

The deed is done. On July 29, President Obama signed a bill that was written by corporations, paid for by corporations and that serves no one in this country—except corporations.

S.764, known by its opponents as the DARK (Deny Americans the Right to Know) Act, preempts Vermont's mandatory GMO labeling law and substitutes in its place a federal bill that, no matter how Obama and his Congress try to spin it, is not mandatory and does not require labels—at least not labels that anyone can read. Not to mention that most GMO ingredients will be exempt under this fake "law."

I could, once again, list all the reasons this bill fails consumers. But I and others have already done that countless times, to no avail. The bill is a sham, a slap in the face to the 90 percent of Americans who support labeling. It's an attack on states' rights. It's another "gift" to Monsanto and Big Food.

And, for anyone who still harbored any doubt, S.764 is proof that our Democracy is broken, that our lawmakers answer to Corporate America, not to us, the people who elect them.

It would be easy, after four-and-a-half years of non-stop fighting for labels, to cave in to despair. But let's not give Monsanto the satisfaction. Because the truth is, while we may not always be able to win in a policy arena awash in corporate money, we, as consumers, still have tremendous power to influence the marketplace.

It's time to wield that power. Against poison-peddling biotech corporations. Against food companies that hide the truth about what's in their products. Against those "leaders" in the organic industry who sold us down the river on GMO labeling.

It's time to launch a Gandhi-style boycott.

If Vermont mounts a legal challenge to the DARK Act, we will endorse that effort. But in the meantime, we will channel our anger, our disappointment and above all, our energy, into the marketplace. Because that's where we as consumers will have last word.

What We've Accomplished So Far

Before we get on to what's next, let's look at what the GMO labeling movement accomplished, despite passage of the DARK Act.

We educated a critical mass of American consumers about the health and environmental hazards of GMOs and the toxic chemicals that accompany them. When we started this battle, public awareness of genetically engineered food and crops and the damage they inflict on the environment and human health, was marginal at best. Today "GMO," "Monsanto" and "glyphosate" are household words.

We've doubled demand for organic and grass-fed food in the U.S. over the past six years. Organic food and grass-fed meat and animal products are now a $50-billion-a-year powerhouse, the fastest-growing segment of the food system. The market for non-GMO labeled products has grown to $25 billion. Organic, grass-fed and non-GMO foods now constitute approximately 10 percent of all grocery store sales and represent a growing segment of restaurant sales as well.

We forced multi-billion-dollar junk food conglomerates, including General Mills, Kellogg's, Campbell's, Mars, Pepsi, Frito-Lay, Dannon, Con-Agra and others to start labeling their products as GMO or else remove GMO ingredients, ahead of the July 1 date for the (short-lived) enactment of Vermont's GMO labeling law. Now that Vermont's law has been preempted, we need to pressure these companies to keep labeling—or we'll call for a boycott of all of their organic products, including their organic brands.

We've alerted millions of consumers that they can't trust the mass media, regulatory agencies or the scientific establishment. If consumers or farmers want truthful information about food and farming they need to tune in to the alternative and social media. This alternative media includes the mass circulation newsletters, websites and Facebook pages of groups like Mercola.com, the Organic Consumers Association, Center for Food Safety, Food Democracy Now, Friends of the Earth, Pesticide Action Network, Moms Across America, Regeneration International, Seed Freedom and hundreds of others that refuse to regurgitate industry propaganda. We need to keep supporting the truth-seekers, like U.S. Right to Know, as they continue to expose Big Food's dark secrets.

Where We Go From Here

It was worth fighting for labels on GMO foods. But we've always known that labels were just one tool in the toolbox. And that the GMOs in the food in our grocery stores are just one piece of a big, bad, dangerous puzzle.

Only about 20 percent of GMOs go into the food we buy. The other 80 percent of all GMO crops go into either animal feed or ethanol fuels. The growing of those crops, which requires millions of tons of pesticides and chemical fertilizers, exacts a terrible toll on our soils, our waters, our health, our future.

It's time to mobilize public consciousness and market pressure and transform our entire degenerate chemical- and energy-intensive industrial food and farming system into a system that regenerates—a system that can restore biodiversity and revitalize public health, animal health, the environment, rural communities and the body politic, while drawing down billions of tons of excess CO2 from the atmosphere and safely sequestering this carbon in the soil and forests, where it belongs.

It's time to drive GMOs off the market, for good.

In the coming weeks and months, we will launch critical new campaigns, some of them international in scope, designed to pressure the bad actors in the food industry to clean up their acts—or risk plummeting sales.

In the meantime, consumers can join the 500,000 people who have already begun exercising their marketplace clout by choosing to boycott brands, including organic brands owned by junk food giants who helped defeat labeling laws. You can download our Boycott/Buycott app here.

We also urge U.S. consumers to join citizens around the world in endorsing the International Monsanto Tribunal, a citizens' tribunal which will take place October 15-16 in The Hague, Netherlands.

As we look to the future of this movement, let's not forget the past. Now would be a good time to take a page out of Gandhi's playbook.

Ronnie Cummins is international director of the Organic Consumers Association and a member of the Regeneration International steering committee.

EcoWatch Daily Newsletter

Supporters cheer before Trump arrives for a rally at the BOK Center on June 20, 2020 in Tulsa, OK. Jabin Botsford / The Washington Post via Getty Images

On Monday and Tuesday of the week that President Donald Trump held his first rally since March in Tulsa, Oklahoma, the county reported 76 and 96 new coronavirus cases respectively, according to POLITICO. This week, the county broke its new case record Monday with 261 cases and reported a further 206 cases on Tuesday. Now, Tulsa's top public health official thinks the rally and counterprotest "likely contributed" to the surge.

Read More Show Less
In the tropics, farmers often slash and burn forests to clear fertile land for crops, but a new method avoids that technique. Inga Foundation video

Rainforests are an important defense against climate change because they absorb carbon. But many are being destroyed on a massive scale.

Read More Show Less
A truck spreads lime on a meadow to increase the soil's fertility in Yorkshire Dales, UK. Farm Images / Universal Images Group via Getty Images

As we look for advanced technology to replace our dependence on fossil fuels and to rid the oceans of plastic, one solution to the climate crisis might simply be found in rocks. New research found that dispersing rock dust over farmland could suck billions of tons of carbon dioxide from the air every year, according to the first detailed large scale analysis of the technique, as The Guardian reported.

Read More Show Less
Global heating imposes a harsh cost at the most critical time of all: the moment of spawning. Pxfuel

By Tim Radford

German scientists now know why so many fish are so vulnerable to ever-warming oceans. Global heating imposes a harsh cost at the most critical time of all: the moment of spawning.

Read More Show Less
Guillain-Barre syndrome occurs when the body's own immune system attacks and injures the nerves outside of the spinal cord or brain – the peripheral nervous system. Niq Steele / Getty Images

By Sherry H-Y. Chou, Aarti Sarwal and Neha S. Dangayach

The patient in the case report (let's call him Tom) was 54 and in good health. For two days in May, he felt unwell and was too weak to get out of bed. When his family finally brought him to the hospital, doctors found that he had a fever and signs of a severe infection, or sepsis. He tested positive for SARS-CoV-2, the virus that causes COVID-19 infection. In addition to symptoms of COVID-19, he was also too weak to move his legs.

When a neurologist examined him, Tom was diagnosed with Guillain-Barre Syndrome, an autoimmune disease that causes abnormal sensation and weakness due to delays in sending signals through the nerves. Usually reversible, in severe cases it can cause prolonged paralysis involving breathing muscles, require ventilator support and sometimes leave permanent neurological deficits. Early recognition by expert neurologists is key to proper treatment.

We are neurologists specializing in intensive care and leading studies related to neurological complications from COVID-19. Given the occurrence of Guillain-Barre Syndrome in prior pandemics with other corona viruses like SARS and MERS, we are investigating a possible link between Guillain-Barre Syndrome and COVID-19 and tracking published reports to see if there is any link between Guillain-Barre Syndrome and COVID-19.

Some patients may not seek timely medical care for neurological symptoms like prolonged headache, vision loss and new muscle weakness due to fear of getting exposed to virus in the emergency setting. People need to know that medical facilities have taken full precautions to protect patients. Seeking timely medical evaluation for neurological symptoms can help treat many of these diseases.

What Is Guillain-Barre Syndrome?

Guillain-Barre syndrome occurs when the body's own immune system attacks and injures the nerves outside of the spinal cord or brain – the peripheral nervous system. Most commonly, the injury involves the protective sheath, or myelin, that wraps nerves and is essential to nerve function.

Without the myelin sheath, signals that go through a nerve are slowed or lost, which causes the nerve to malfunction.

To diagnose Guillain-Barre Syndrome, neurologists perform a detailed neurological exam. Due to the nerve injury, patients often may have loss of reflexes on examination. Doctors often need to perform a lumbar puncture, otherwise known as spinal tap, to sample spinal fluid and look for signs of inflammation and abnormal antibodies.

Studies have shown that giving patients an infusion of antibodies derived from donated blood or plasma exchange – a process that cleans patients' blood of harmful antibodies - can speed up recovery. A very small subset of patients may need these therapies long-term.

The majority of Guillain-Barre Syndrome patients improve within a few weeks and eventually can make a full recovery. However, some patients with Guillain-Barre Syndrome have lingering symptoms including weakness and abnormal sensations in arms and/or legs; rarely patients may be bedridden or disabled long-term.

Guillain-Barre Syndrome and Pandemics

As the COVID-19 pandemic sweeps across the globe, many neurologic specialists have been on the lookout for potentially serious nervous system complications such as Guillain-Barre Syndrome.

Though Guillain-Barre Syndrome is rare, it is well known to emerge following bacterial infections, such as Campylobacter jejuni, a common cause of food poisoning, and a multitude of viral infections including the flu virus, Zika virus and other coronaviruses.

Studies showed an increase in Guillain-Barre Syndrome cases following the 2009 H1N1 flu pandemic, suggesting a possible connection. The presumed cause for this link is that the body's own immune response to fight the infection turns on itself and attacks the peripheral nerves. This is called an "autoimmune" condition. When a pandemic affects as many people as our current COVID-19 crisis, even a rare complication can become a significant public health problem. That is especially true for one that causes neurological dysfunction where the recovery takes a long time and may be incomplete.

The first reports of Guillain-Barre Syndrome in COVID-19 pandemic originated from Italy, Spain and China, where the pandemic surged before the U.S. crisis.

Though there is clear clinical suspicion that COVID-19 can lead to Guillain-Barre Syndrome, many important questions remain. What are the chances that someone gets Guillain-Barre Syndrome during or following a COVID-19 infection? Does Guillain-Barre Syndrome happen more often in those who have been infected with COVID-19 compared to other types of infections, such as the flu?

The only way to get answers is through a prospective study where doctors perform systematic surveillance and collect data on a large group of patients. There are ongoing large research consortia hard at work to figure out answers to these questions.

Understanding the Association Between COVID-19 and Guillain-Barre Syndrome

While large research studies are underway, overall it appears that Guillain-Barre Syndrome is a rare but serious phenomenon possibly linked to COVID-19. Given that more than 10.7 million cases have been reported for COVID-19, there have been 10 reported cases of COVID-19 patients with Guillain-Barre Syndrome so far – only two reported cases in the U.S., five in Italy, two cases in Iran and one from Wuhan, China.

It is certainly possible that there are other cases that have not been reported. The Global Consortium Study of Neurological Dysfunctions in COVID-19 is actively underway to find out how often neurological problems like Guillain-Barre Syndrome is seen in hospitalized COVID-19 patients. Also, just because Guillain-Barre Syndrome occurs in a patient diagnosed with COVID-19, that does not imply that it was caused by the virus; this still may be a coincident occurrence. More research is needed to understand how the two events are related.

Due to the pandemic and infection-containment considerations, diagnostic tests, such as a nerve conduction study that used to be routine for patients with suspected Guillain-Barre Syndrome, are more difficult to do. In both U.S. cases, the initial diagnosis and treatment were all based on clinical examination by a neurological experts rather than any tests. Both patients survived but with significant residual weakness at the time these case reports came out, but that is not uncommon for Guillain-Barre Syndrome patients. The road to recovery may sometimes be long, but many patients can make a full recovery with time.

Though the reported cases of Guillain-Barre Syndrome so far all have severe symptoms, this is not uncommon in a pandemic situation where the less sick patients may stay home and not present for medical care for fear of being exposed to the virus. This, plus the limited COVID-19 testing capability across the U.S., may skew our current detection of Guillain-Barre Syndrome cases toward the sicker patients who have to go to a hospital. In general, the majority of Guillain-Barre Syndrome patients do recover, given enough time. We do not yet know whether this is true for COVID-19-related cases at this stage of the pandemic. We and colleagues around the world are working around the clock to find answers to these critical questions.

Sherry H-Y. Chou is an Associate Professor of Critical Care Medicine, Neurology, and Neurosurgery, University of Pittsburgh.

Aarti Sarwal is an Associate Professor, Neurology, Wake Forest University.

Neha S. Dangayach is an Assistant Professor of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai.

Disclosure statement: Sherry H-Y. Chou receives funding from The University of Pittsburgh Clinical Translational Science Institute (CTSI), the National Institute of Health, and the University of Pittsburgh School of Medicine Dean's Faculty Advancement Award. Sherry H-Y. Chou is a member of Board of Directors for the Neurocritical Care Society. Neha S. Dangayach receives funding from the Bee Foundation, the Friedman Brain Institute, the Neurocritical Care Society, InCHIP-UConn Center for mHealth and Social Media Seed Grant. She is faculty for emcrit.org and for AiSinai. Aarti Sarwal does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Reposted with permission from The Conversation.


Nurses wear PPE prior to caring for a COVID-19 patient in the ICU at Sharp Grossmont Hospital on May 5, 2020 in La Mesa, California. Mario Tama / Getty Images

One of the initial reasons social distancing guidelines were put in place was to allow the healthcare system to adapt to a surge in patients since there was a critical shortage of beds, ventilators and personal protective equipment. In fact, masks that were designed for single-use were reused for an entire week in some hospitals.

Read More Show Less

Trending

Democratic presidential hopefuls Joe Biden and Senator Bernie Sanders greet each other with a safe elbow bump before the start of the Democratic Party 2020 presidential debate in a CNN Washington Bureau studio in Washington, DC on March 15, 2020. Mandel Ngan / AFP / Getty Images

By Jake Johnson

Unity Task Forces formed by presumptive Democratic presidential nominee Joe Biden and Sen. Bernie Sanders unveiled sweeping party platform recommendations Wednesday that—while falling short of progressive ambitions in a number of areas, from climate to healthcare—were applauded as important steps toward a bold and just policy agenda that matches the severity of the moment.

"We've moved the needle a lot, especially on environmental justice and upping Biden's ambition," said Sunrise Movement co-founder and executive director Varshini Prakash, a member of the Biden-Sanders Climate Task Force. "But there's still more work to do to push Democrats to act at the scale of the climate crisis."

The climate panel—co-chaired by Rep. Alexandria Ocasio-Cortez (D-N.Y.) and former Secretary of State John Kerry—recommended that the Democratic Party commit to "eliminating carbon pollution from power plants by 2035," massively expanding investments in clean energy sources, and "achieving net-zero greenhouse gas emissions for all new buildings by 2030."

In a series of tweets Wednesday night, Ocasio-Cortez—the lead sponsor of the House Green New Deal resolution—noted that the Climate Task Force "shaved 15 years off Biden's previous target for 100% clean energy."

"Of course, like in any collaborative effort, there are areas of negotiation and compromise," said the New York Democrat. "But I do believe that the Climate Task Force effort meaningfully and substantively improved Biden's positions."

 

The 110 pages of policy recommendations from the six eight-person Unity Task Forces on education, the economy, criminal justice, immigration, climate change, and healthcare are aimed at shaping negotiations over the 2020 Democratic platform at the party's convention next month.

Sanders said that while the "end result isn't what I or my supporters would've written alone, the task forces have created a good policy blueprint that will move this country in a much-needed progressive direction and substantially improve the lives of working families throughout our country."

"I look forward to working with Vice President Biden to help him win this campaign," the Vermont senator added, "and to move this country forward toward economic, racial, social, and environmental justice."

Biden, for his part, applauded the task forces "for helping build a bold, transformative platform for our party and for our country."

"I am deeply grateful to Bernie Sanders for working with us to unite our party and deliver real, lasting change for generations to come," said the former vice president.

On the life-or-death matter of reforming America's dysfunctional private health insurance system—a subject on which Sanders and Biden clashed repeatedly throughout the Democratic primary process—the Unity Task Force affirmed healthcare as "a right" but did not embrace Medicare for All, the signature policy plank of the Vermont senator's presidential bid.

Instead, the panel recommended building on the Affordable Care Act by establishing a public option, investing in community health centers, and lowering prescription drug costs by allowing the federal government to negotiate prices. The task force also endorsed making all Covid-19 testing, treatments, and potential vaccines free and expanding Medicaid for the duration of the pandemic.

"It has always been a crisis that tens of millions of Americans have no or inadequate health insurance—but in a pandemic, it's potentially catastrophic for public health," the task force wrote.

Dr. Abdul El-Sayed, a former Michigan gubernatorial candidate and Sanders-appointed member of the Healthcare Task Force, said that despite major disagreements, the panel "came to recommendations that will yield one of the most progressive Democratic campaign platforms in history—though we have further yet to go."

 

Observers and advocacy groups also applauded the Unity Task Forces for recommending the creation of a postal banking system, endorsing a ban on for-profit charter schools, ending the use of private prisons, and imposing a 100-day moratorium on deportations "while conducting a full-scale study on current practices to develop recommendations for transforming enforcement policies and practices at ICE and CBP."

Marisa Franco, director of immigrant rights group Mijente, said in a statement that "going into these task force negotiations, we knew we were going to have to push Biden past his comfort zone, both to reconcile with past offenses and to carve a new path forward."

"That is exactly what we did, unapologetically," said Franco, a member of the Immigration Task Force. "For years, Mijente, along with the broader immigrant rights movement, has fought to reshape the narrative around immigration towards racial justice and to focus these very demands. We expect Biden and the Democratic Party to implement them in their entirety."

"There is no going back," Franco added. "Not an inch, not a step. We must only move forward from here."

Reposted with permission from Common Dreams.